Appeals

The valuer general has knocked arguments by developer WSTI Properties in a High Court dispute over a heritage property in Melbourne, saying the contentions are "unavailable and unsound”. 

EPC Pacific is facing a fight after it got the go-ahead from Yarra City Council to build an 11-storey mixed use office building in an inner city Melbourne suburb.

Otsuka Pharmaceuticals is challenging a decision revoking its patent for an injectable version of antipsychotic drug Abilify.

Canberra developer Geocon has filed a legal challenge seeking a tax refund on sales from a development for 360 residential units. 

The High Court has been asked to overturn a ruling that found India was immune from a suit seeking to enforce a $111.3 million arbitral award because it did not involve a 'commercial' matter.

An appeals court has tossed a challenge to a judge's decision that found a property developer was required to return a $1.3 million loan, despite finding the judge erred in holding enforceable an agreement reached over email.

Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.

An appeals court has found water infrastructure investor Conexa liable to pay land duty on a $46 million Sydney pipeline it acquired as part of a blockbuster deal with Rosehill.

Munich Reinsurance has been given the OK to bring additional claims in its $696 million lawsuit, which accuses AMP of misleading or deceptive conduct over a quota share agreement.

A former capital partner of HWL Ebsworth wants the High Court to overturn a finding that he was validly expelled from the partnership, arguing the firm’s conduct breached the Equal Opportunity Act.